Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dermatologists Challenge New Zealand Easing Of Acne Drug Rules

This article was originally published in PharmAsia News

Executive Summary

Dermatologists in Australia and New Zealand are fighting a decision by New Zealand's Pharmaceutical Management Agency to ease restrictions on who can administer acne drugs. Pharmac issued a ruling to allow general practitioners and not just dermatologists to administer isotretinoin, sold as Roche's Accutane in the United States. Dermatologist groups in Australia and New Zealand termed the drug potentially dangerous and said their members have been cautious about administering it. They expressed concern that general practitioners may not be as aware of the drug's safety problems, but a Pharmac director said it had weighed carefully all information about isotretinoin. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067481

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel